Pepto-Bismol

Name

Pepto-Bismol

Legal name

Procter & Gamble

Website

https://pepto-bismol.com

Company type

Private

Founded year

1901

Operating status

Operating

Headcount range

101–250 employees

Ownership category

akta.pro rank

Product category

Over-the-counter digestive health

NAICS

Sugar and Confectionery Product Manufacturing (3113)

SIC

Miscellaneous Food Preparations & Kindred Products (2090)

akta.pro primary industry

Digestive Health OTC (Antacids, Laxatives, Anti-diarrheals, Probiotics OTC) (CRADAMAE)

akta.pro secondary industries

Gastrointestinal & Digestive Health (HLAIADAD), Functional Foods & Supplement Formats (Gummies, Chews, Powders, Shots) (CRADAGAI)

Keywords

• Over-the-counter medications
• Digestive health products
• Upset stomach relief
• Antidiarrheal medications
• OTC pharmaceuticals

Headquarters

HQ city

Cincinnati

HQ country

United States

HQ region

North America

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Marketing or Sales, Supply Chain, Operations, Personnel, Technology or R&D

Revenue model

1. OTC Pharmaceutical Product Sales: Pepto-Bismol generates revenue through the sale of over-the-counter upset stomach and digestive relief products. The brand offers multiple product lines (Original, Ultra, Kids, Targeted Relief) sold through retail and pharmacy channels. Revenue is generated through one-time purchase transactions at retail stores.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

Pepto-Bismol manufactures and markets over-the-counter (OTC) digestive relief products containing bismuth subsalicylate, simethicone, and meclizine HCl. The brand offers multi-symptom relief (nausea, heartburn, indigestion, upset stomach, and diarrhea) in liquid, chewable tablet, caplet, liquicap, chew, and gummy forms across Original, Ultra, Kids, Nausea, and Gas + Bloating lines. Products are sold through mass retail and pharmacy channels in the United States.

Product overview

Pepto-Bismol is a portfolio of over-the-counter digestive health products organized into three main categories: Multi-Symptom Relief (Original and Ultra sub-brands using bismuth subsalicylate for 5-symptom relief), Kids products (bubblegum-flavored formulations for children ages 2+), and Targeted Relief (Pepto Nausea for motion sickness and Pepto Gas + Bloating using simethicone). The core Original line offers liquids, caplets, chewables, chews, fast melts, and liquicaps in various flavors (original wintergreen, cherry, berry mint). Ultra variants provide 2X concentrated formulas. Products are distributed by Procter & Gamble and are HSA/FSA eligible.

Differentiator

Problem solved

Functional benefit

Brands

• Pepto Bismol Original: Classic Pepto formula providing 5-symptom relief for nausea, heartburn, indigestion, upset stomach, and diarrhea.
• Pepto Bismol Ultra
• Pepto Kids
• Pepto Nausea
• Pepto Gas + Bloating
• Pepto LiquiCaps

Products and services

• Pepto Bismol Original Liquid Classic pink liquid form providing 5-symptom relief (nausea, heartburn, indigestion, upset stomach, diarrhea) with bismuth subsalicylate. Available in 16 oz bottle for adult consumers.
• Pepto Bismol Original Liquid - Cherry Flavor

Quantifiable outcome

• #1 Pharmacist Recommended Brand for Upset Stomach - based on Pharmacy Times Survey

Segments3 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• Prilosec OTC: Procter & Gamble's own OTC proton pump inhibitor for frequent heartburn. Same parent company as Pepto-Bismol, representing portfolio overlap rather than pure competition within P&G's digestive health franchise.

Direct peers

• Pepcid: Johnson & Johnson's OTC acid reducer (famotidine). Competes with Pepto-Bismol for heartburn and sour stomach occasions, often adjacent on the same retailer shelves.
• Alka-Seltzer: Bayer's flagship effervescent digestive relief brand. Competes with Pepto in heartburn, indigestion, and upset stomach, with similar long-standing brand heritage and broad US distribution.
• Phillips': Bayer's magnesium-based digestive brand (Milk of Magnesia, stool softeners). Adjacent digestive health competitor that competes with Pepto in occasional upset stomach and related symptom categories.
• Tums: Haleon's (formerly GSK Consumer Healthcare) leading antacid chewable brand. Directly competes with Pepto on heartburn and indigestion relief across the same pharmacy and grocery channels.
• Rolaids: Antacid brand now owned by Haleon. Directly competes with Pepto in the heartburn/acid indigestion segment across mass retail and pharmacy channels.
• Imodium: Johnson & Johnson's flagship anti-diarrheal OTC brand (loperamide). Directly competes with Pepto-Bismol in the anti-diarrheal segment and traveler's diarrhea use case that Pepto explicitly targets.
• Kaopectate: OTC anti-diarrheal and upset stomach brand also based on bismuth subsalicylate, historically owned by Chattem/Sanofi. Directly competes with Pepto-Bismol on the same active ingredient and same core symptoms (diarrhea, upset stomach).
• MiraLAX: Bayer's leading osmotic laxative powder brand. Sits adjacent to Pepto's digestive health portfolio and competes for the same household 'digestive remedies' budget at retail.

Emerging players

• Nexium 24HR: AstraZeneca/Pfizer OTC version of the prescription proton pump inhibitor esomeprazole. Competes with Pepto-Bismol for heartburn sufferers, particularly in the frequent-heartburn segment where Pepto's episodic positioning is weaker.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/pepto
• YouTubeyoutube.com/peptobismol
• Facebookfacebook.com/peptobismol

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pepto-Bismol